Cargando…

GCN2 Deficiency Enhances Protective Effects of Exercise on Hepatic Steatosis

BACKGROUND: Combined aerobic and resistance training has been demonstrated to benefit glycemic control and reverse nonalcoholic fatty liver disease in childhood obesity. General control nonderepressible 2 (GCN2) deficiency has been reported to attenuate hepatic steatosis and insulin resistance. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xueting, Shi, Xiaowei, Sun, Zhongguang, Xiao, Jing, Song, Hui, Lu, Guo, Xu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707946/
https://www.ncbi.nlm.nih.gov/pubmed/33299856
http://dx.doi.org/10.1155/2020/1454396
_version_ 1783617462209609728
author Luo, Xueting
Shi, Xiaowei
Sun, Zhongguang
Xiao, Jing
Song, Hui
Lu, Guo
Xu, Xin
author_facet Luo, Xueting
Shi, Xiaowei
Sun, Zhongguang
Xiao, Jing
Song, Hui
Lu, Guo
Xu, Xin
author_sort Luo, Xueting
collection PubMed
description BACKGROUND: Combined aerobic and resistance training has been demonstrated to benefit glycemic control and reverse nonalcoholic fatty liver disease in childhood obesity. General control nonderepressible 2 (GCN2) deficiency has been reported to attenuate hepatic steatosis and insulin resistance. However, whether GCN2 impacts the positive effects of combined aerobic and resistance exercise remains unknown. OBJECTIVES: To investigate whether combined aerobic and resistance exercise improves hepatic steatosis and glucose intolerance and the role GCN2 plays in mediating the metabolic regulation of exercise. METHODS: Wild-type (WT) and GCN2 knockout (GCN2KO) mice were fed a high-fat diet (HFD) for 25 weeks. The WT and GCN2KO mice performed exercise (treadmill running + ladder climbing) during the last eight weeks. Their body and liver weights, their triglyceride content, and their levels of aspartate transaminase (AST), alanine transaminase (ALT), and blood glucose were measured, and the expressions of proteins involved in the GCN2/eIF2α/ATF4 pathway and the glucolipid metabolism-related proteins (e.g., p-AMPK, SIRT1, PPARα, PGC-1α, GLUT4, and p-GSK-3β) were determined. RESULTS: The body weight of WT and GCN2KO mice continued to increase until the end of the experiment. The liver weights, hepatic triglyceride content, and AST and ALT levels of the exercised mice were significantly reduced compared to those of the sedentary mice. Exercise improved blood glucose levels and glucose clearance ability in the WT mice, but the glucose intolerance of GCN2KO mice was not improved. Exercise increased PGC-1α, GLUT4, and p-GSK-3β expressions in the WT rather than the GCN2KO mice. Interestingly however, exercise-trained GCN2KO mice were better protected against hepatic steatosis with downregulated expressions of p-eIF2α and ATF4, upregulated expressions of p-AMPK and SIRT1, and the presence of PPARα in the liver, compared to the exercised WT mice. CONCLUSION: Combined aerobic and resistance exercise had positive effects on hepatic steatosis and the control of glucose intolerance. GCN2 was found to be necessary for exercise-induced improved glucose intolerance. However, the better efficacy in improving hepatic steatosis by exercise in the GCN2-deficient mice enhanced liver lipid metabolism, at least partially, via the AMPK/SIRT1/PPARα pathway.
format Online
Article
Text
id pubmed-7707946
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-77079462020-12-08 GCN2 Deficiency Enhances Protective Effects of Exercise on Hepatic Steatosis Luo, Xueting Shi, Xiaowei Sun, Zhongguang Xiao, Jing Song, Hui Lu, Guo Xu, Xin Biomed Res Int Research Article BACKGROUND: Combined aerobic and resistance training has been demonstrated to benefit glycemic control and reverse nonalcoholic fatty liver disease in childhood obesity. General control nonderepressible 2 (GCN2) deficiency has been reported to attenuate hepatic steatosis and insulin resistance. However, whether GCN2 impacts the positive effects of combined aerobic and resistance exercise remains unknown. OBJECTIVES: To investigate whether combined aerobic and resistance exercise improves hepatic steatosis and glucose intolerance and the role GCN2 plays in mediating the metabolic regulation of exercise. METHODS: Wild-type (WT) and GCN2 knockout (GCN2KO) mice were fed a high-fat diet (HFD) for 25 weeks. The WT and GCN2KO mice performed exercise (treadmill running + ladder climbing) during the last eight weeks. Their body and liver weights, their triglyceride content, and their levels of aspartate transaminase (AST), alanine transaminase (ALT), and blood glucose were measured, and the expressions of proteins involved in the GCN2/eIF2α/ATF4 pathway and the glucolipid metabolism-related proteins (e.g., p-AMPK, SIRT1, PPARα, PGC-1α, GLUT4, and p-GSK-3β) were determined. RESULTS: The body weight of WT and GCN2KO mice continued to increase until the end of the experiment. The liver weights, hepatic triglyceride content, and AST and ALT levels of the exercised mice were significantly reduced compared to those of the sedentary mice. Exercise improved blood glucose levels and glucose clearance ability in the WT mice, but the glucose intolerance of GCN2KO mice was not improved. Exercise increased PGC-1α, GLUT4, and p-GSK-3β expressions in the WT rather than the GCN2KO mice. Interestingly however, exercise-trained GCN2KO mice were better protected against hepatic steatosis with downregulated expressions of p-eIF2α and ATF4, upregulated expressions of p-AMPK and SIRT1, and the presence of PPARα in the liver, compared to the exercised WT mice. CONCLUSION: Combined aerobic and resistance exercise had positive effects on hepatic steatosis and the control of glucose intolerance. GCN2 was found to be necessary for exercise-induced improved glucose intolerance. However, the better efficacy in improving hepatic steatosis by exercise in the GCN2-deficient mice enhanced liver lipid metabolism, at least partially, via the AMPK/SIRT1/PPARα pathway. Hindawi 2020-11-24 /pmc/articles/PMC7707946/ /pubmed/33299856 http://dx.doi.org/10.1155/2020/1454396 Text en Copyright © 2020 Xueting Luo et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Luo, Xueting
Shi, Xiaowei
Sun, Zhongguang
Xiao, Jing
Song, Hui
Lu, Guo
Xu, Xin
GCN2 Deficiency Enhances Protective Effects of Exercise on Hepatic Steatosis
title GCN2 Deficiency Enhances Protective Effects of Exercise on Hepatic Steatosis
title_full GCN2 Deficiency Enhances Protective Effects of Exercise on Hepatic Steatosis
title_fullStr GCN2 Deficiency Enhances Protective Effects of Exercise on Hepatic Steatosis
title_full_unstemmed GCN2 Deficiency Enhances Protective Effects of Exercise on Hepatic Steatosis
title_short GCN2 Deficiency Enhances Protective Effects of Exercise on Hepatic Steatosis
title_sort gcn2 deficiency enhances protective effects of exercise on hepatic steatosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707946/
https://www.ncbi.nlm.nih.gov/pubmed/33299856
http://dx.doi.org/10.1155/2020/1454396
work_keys_str_mv AT luoxueting gcn2deficiencyenhancesprotectiveeffectsofexerciseonhepaticsteatosis
AT shixiaowei gcn2deficiencyenhancesprotectiveeffectsofexerciseonhepaticsteatosis
AT sunzhongguang gcn2deficiencyenhancesprotectiveeffectsofexerciseonhepaticsteatosis
AT xiaojing gcn2deficiencyenhancesprotectiveeffectsofexerciseonhepaticsteatosis
AT songhui gcn2deficiencyenhancesprotectiveeffectsofexerciseonhepaticsteatosis
AT luguo gcn2deficiencyenhancesprotectiveeffectsofexerciseonhepaticsteatosis
AT xuxin gcn2deficiencyenhancesprotectiveeffectsofexerciseonhepaticsteatosis